314 — Sipai Health Technology Co, Share Price
Last trade - 00:00- HK$3.32bn
- HK$2.36bn
- CNY4.57bn
- 41
- 27
- 42
- 27
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 51.1 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.59 | ||
| Price to Tang. Book | 2.69 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.7 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -29.09% | ||
| Return on Equity | -22.76% | ||
| Operating Margin | -7.83% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 2,699.65 | 3,473.93 | 4,119.48 | 4,712.11 | 4,565.43 | 6,519.65 | 7,443.78 | 34.45% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +180 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sipai Health Technology Co Ltd is an investment holding company principally engaged in providing medical and health services. The Company operates its businesses through three segments. Specialty Pharmacy Business segment is mainly engaged in operation of specialty pharmacy stores and distribution of pharmaceutical products to pharmaceutical companies and other distributors. Physician Research Assistance Business segment mainly offers pharmaceutical companies and other clinical trial institutions site management organization services, including site feasibility, site initiation, patient recruitment, patient management, data entry and document management, on-site drug management and bio-sample management, site closure and others, and offering services for image management in clinical trials. Health Insurance Services Business segment mainly provides insurance brokerage services to insurance companies and health management services to insurance carriers and enterprise clients.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 19th, 2015
- Public Since
- December 23rd, 2022
- No. of Employees
- 3,247
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 764,182,114
- Address
- Units 11-13, 26/F, Tower A, GUANGZHOU
- Web
- https://www.medbankshealthtech.com/
- Phone
- Auditors
- Ernst & Young
Upcoming Events for 314
Similar to 314
Alibaba Health Information Technology
Stock Exchange of Hong Kong Limited
Alpha Professional Holdings
Stock Exchange of Hong Kong Limited
Asia Grocery Distribution
Stock Exchange of Hong Kong Limited
Best Mart 360 Holdings
Stock Exchange of Hong Kong Limited
Beijing Properties (Holdings)
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 23:16 UTC, shares in Sipai Health Technology Co, are trading at HK$4.43. This share price information is delayed by 15 minutes.
Shares in Sipai Health Technology Co, last closed at HK$4.43 and the price had moved by -23.88% over the past 365 days. In terms of relative price strength the Sipai Health Technology Co, share price has underperformed the FTSE Developed Asia Pacific Index by -23.01% over the past year.
The overall consensus recommendation for Sipai Health Technology Co, is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreSipai Health Technology Co, does not currently pay a dividend.
Sipai Health Technology Co, does not currently pay a dividend.
Sipai Health Technology Co, does not currently pay a dividend.
To buy shares in Sipai Health Technology Co, you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$4.43, shares in Sipai Health Technology Co, had a market capitalisation of HK$3.32bn.
Here are the trading details for Sipai Health Technology Co,:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 314
Based on an overall assessment of its quality, value and momentum Sipai Health Technology Co, is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Sipai Health Technology Co, is HK$11.92. That is 169.14% above the last closing price of HK$4.43.
Analysts covering Sipai Health Technology Co, currently have a consensus Earnings Per Share (EPS) forecast of CNY0.05 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sipai Health Technology Co,. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -10.93%.
As of the last closing price of HK$4.43, shares in Sipai Health Technology Co, were trading -18.18% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Sipai Health Technology Co, PE ratio based on its reported earnings over the past 12 months is 51.1. The shares last closed at HK$4.43.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Sipai Health Technology Co,'s directors